Prediction of Transmembrane Regions, Cholesterol, and Ganglioside Binding Sites in Amyloid-Forming Proteins Indicate Potential for Amyloid Pore Formation
Overview
Affiliations
Besides amyloid fibrils, amyloid pores (APs) represent another mechanism of amyloid induced toxicity. Since hypothesis put forward by Arispe and collegues in 1993 that amyloid-beta makes ion-conducting channels and that Alzheimer's disease may be due to the toxic effect of these channels, many studies have confirmed that APs are formed by prefibrillar oligomers of amyloidogenic proteins and are a common source of cytotoxicity. The mechanism of pore formation is still not well-understood and the structure and imaging of APs in living cells remains an open issue. To get closer to understand AP formation we used predictive methods to assess the propensity of a set of 30 amyloid-forming proteins (AFPs) to form transmembrane channels. A range of amino-acid sequence tools were applied to predict AP domains of AFPs, and provided context on future experiments that are needed in order to contribute toward a deeper understanding of amyloid toxicity. In a set of 30 AFPs we predicted their amyloidogenic propensity, presence of transmembrane (TM) regions, and cholesterol (CBM) and ganglioside binding motifs (GBM), to which the oligomers likely bind. Noteworthy, all pathological AFPs share the presence of TM, CBM, and GBM regions, whereas the functional amyloids seem to show just one of these regions. For comparative purposes, we also analyzed a few examples of amyloid proteins that behave as biologically non-relevant AFPs. Based on the known experimental data on the β-amyloid and α-synuclein pore formation, we suggest that many AFPs have the potential for pore formation. Oligomerization and α-TM helix to β-TM strands transition on lipid rafts seem to be the common key events.
Lipid rafts and human diseases: why we need to target gangliosides.
Fantini J FEBS Open Bio. 2023; 13(9):1636-1650.
PMID: 37052878 PMC: 10476576. DOI: 10.1002/2211-5463.13612.
Ye Q, Wang Q, Lee W, Xiang Y, Yuan J, Zhang Y Toxins (Basel). 2023; 15(3).
PMID: 36977082 PMC: 10054870. DOI: 10.3390/toxins15030191.
Azzaz F, Chahinian H, Yahi N, Fantini J, Di Scala C Int J Mol Sci. 2023; 24(2).
PMID: 36675271 PMC: 9864847. DOI: 10.3390/ijms24021760.
Di Scala C, Armstrong N, Chahinian H, Chabriere E, Fantini J, Yahi N Int J Mol Sci. 2022; 23(21).
PMID: 36362170 PMC: 9654333. DOI: 10.3390/ijms232113383.
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.
Rudajev V, Novotny J Front Mol Neurosci. 2022; 15:937056.
PMID: 36090253 PMC: 9453481. DOI: 10.3389/fnmol.2022.937056.